ASND · US market

Ascendis Pharma A/S

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$14.93bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E17.23×

Latest-quarter run-rate P/E15.44×

Trailing P/S12.21×

Latest-quarter run-rate P/S9.42×

Calculation inputs

Trailing earnings: US$866.34m
Latest-quarter run-rate earnings: US$966.92m
Latest fiscal-year earnings: -US$266.33m
Trailing revenue: US$1.22bn
Latest-quarter run-rate revenue: US$1.59bn
Latest fiscal-year revenue: US$841.08m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

MEDI · Harbor Health Care ETF15.56% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
ARTMX · Artisan Mid Cap Fund Investor Class4.51% weight · Holdings dated 30 June 2026
TFGRX · Touchstone Mid Cap Growth Fund Class R63.68% weight · Holdings dated 30 June 2026
SPYGX · Spyglass Growth Fund Institutional Shares3.08% weight · Holdings dated 30 June 2026
AFOS · ARS Focused Opportunities Strategy ETF3.01% weight · Holdings dated 29 May 2026
ACFNX · American Century Investments Focused Dynamic Growth Fund R6 Class2.76% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
FMED · Fidelity Disruptive Medicine ETF2.11% weight · Holdings dated 31 May 2026
OTCKX · MFS Mid Cap Growth Fund Class R62.07% weight · Holdings dated 31 May 2026
TMED · T. Rowe Price Health Care ETF1.60% weight · Holdings dated 30 June 2026
WEGRX · Allspring Emerging Growth Fund - Class R61.47% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 163 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.